Skip to content

A randomized, double-blind, placebo-controlled trial to evaluate the role of curcumin in prostate cancer patients with intermittent androgen deprivation.

Randomized controlled trial · Prostate · 2019. Source record refreshed; an explanation has not been reviewed.

Randomized controlled trialSource: PubMed · PMID 30671976

About this paper

This page identifies the publication and its source. A checked explanation of its findings is not yet available.

Reading this record

Checking bibliographic metadata does not verify a study’s conclusions or any advice previously linked to it.

CHECK THE ORIGINAL

Publication details

A randomized, double-blind, placebo-controlled trial to evaluate the role of curcumin in prostate cancer patients with intermittent androgen deprivation.

Choi YH, Han DH, Kim SW et al.
Prostate · 2019

PubMed ID
30671976
Record checked

A checked publication record confirms source details. It does not verify a health claim or assess the quality of the study. Our approach.